Related Experiment Video

Updated: May 3, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

8.8K

Suppression of the human carcinoma phenotype by an antioncogene ribozyme

T Shitara1, K J Scanlon

  • 1Department of Urology, Kitasato University Hospital, Kitasato, Japan.

Methods in Molecular Medicine
|February 5, 2014
PubMed

Insights

Oncogenes drive cancer progression by altering cell growth and function. Targeting these specific genes offers a promising strategy for developing effective, tissue-specific cancer gene therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Neoplasia progression is linked to various oncogenes.
  • Key oncogene categories include growth factors/receptors, kinases, and nuclear proteins like Fos/Jun.
  • Tumor suppressor genes also play a critical role in cancer development.

Purpose of the Study:

  • To elucidate the role of specific oncogenes in cancer progression.
  • To identify potential tissue-specific targets for cancer gene therapy.

Main Methods:

  • Literature review and analysis of identified oncogenes.
  • Categorization of oncogenes based on function (e.g., growth factors, kinases, nuclear proteins).

Main Results:

  • Identified oncogenes involved in neoplasia include growth factors/receptors, kinases, nuclear proteins (Fos/Jun), and tumor suppressor genes.
  • Perturbation of these genes can lead to cellular transformation and metastasis.

Conclusions:

  • Understanding oncogene roles is crucial for cancer research.
  • Targeting specific oncogenes provides a rational basis for developing tissue-specific cancer gene therapies.

More Related Videos

Inducible and Reversible Dominant-negative DN Protein Inhibition08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

7.7K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.3K

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

1.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K